A citation-based method for searching scientific literature

Javier A Baena-Del Valle, Qizhi Zheng, David M Esopi, Michael Rubenstein, Gretchen K Hubbard, Maria C Moncaliano, Andrew Hruszkewycz, Ajay Vaghasia, Srinivasan Yegnasubramanian, Sarah J Wheelan, Alan K Meeker, Christopher M Heaphy, Mindy K Graham, Angelo M De Marzo. J Pathol 2018
Times Cited: 23







List of co-cited articles
276 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
30

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
829
21

MYC and Prostate Cancer.
Cheryl M Koh, Charles J Bieberich, Chi V Dang, William G Nelson, Srinivasan Yegnasubramanian, Angelo M De Marzo. Genes Cancer 2010
159
21

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis.
Bora Gurel, Tsuyoshi Iwata, Cheryl M Koh, Robert B Jenkins, Fusheng Lan, Chi Van Dang, Jessica L Hicks, James Morgan, Toby C Cornish, Siobhan Sutcliffe,[...]. Mod Pathol 2008
262
21

The telomerase reverse transcriptase regulates chromatin state and DNA damage responses.
Kenkichi Masutomi, Richard Possemato, Judy M Y Wong, Jennifer L Currier, Zuzana Tothova, Judith B Manola, Shridar Ganesan, Peter M Lansdorp, Kathleen Collins, William C Hahn. Proc Natl Acad Sci U S A 2005
251
21

Secondary structure of vertebrate telomerase RNA.
J L Chen, M A Blasco, C W Greider. Cell 2000
433
17

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
17

Cancer-associated TERT promoter mutations abrogate telomerase silencing.
Kunitoshi Chiba, Joshua Z Johnson, Jacob M Vogan, Tina Wagner, John M Boyle, Dirk Hockemeyer. Elife 2015
136
17


Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene.
Cheryl M Koh, Bora Gurel, Siobhan Sutcliffe, Martin J Aryee, Denise Schultz, Tsuyoshi Iwata, Motohide Uemura, Karen I Zeller, Uzoma Anele, Qizhi Zheng,[...]. Am J Pathol 2011
67
17

A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.
Andrew S Venteicher, Eladio B Abreu, Zhaojing Meng, Kelly E McCann, Rebecca M Terns, Timothy D Veenstra, Michael P Terns, Steven E Artandi. Science 2009
336
13

Stable association of hsp90 and p23, but Not hsp70, with active human telomerase.
H L Forsythe, J L Jarvis, J W Turner, L W Elmore, S E Holt. J Biol Chem 2001
170
13

Telomeres shorten during ageing of human fibroblasts.
C B Harley, A B Futcher, C W Greider. Nature 1990
13

Telomeres and telomerase in cancer.
Steven E Artandi, Ronald A DePinho. Carcinogenesis 2010
486
13

Origin of concatemeric T7 DNA.
J D Watson. Nat New Biol 1972
13

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
13


Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.
Alan K Meeker, Jessica L Hicks, Elizabeth A Platz, Gerrun E March, Christina J Bennett, Michael J Delannoy, Angelo M De Marzo. Cancer Res 2002
196
13

Telomerase activity: a prevalent marker of malignant human prostate tissue.
H J Sommerfeld, A K Meeker, M A Piatyszek, G S Bova, J W Shay, D S Coffey. Cancer Res 1996
369
13

Direct activation of TERT transcription by c-MYC.
K J Wu, C Grandori, M Amacker, N Simon-Vermot, A Polack, J Lingner, R Dalla-Favera. Nat Genet 1999
698
13

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.
R K Moyzis, J M Buckingham, L S Cram, M Dani, L L Deaven, M D Jones, J Meyne, R L Ratliff, J R Wu. Proc Natl Acad Sci U S A 1988
13

Extension of life-span by introduction of telomerase into normal human cells.
A G Bodnar, M Ouellette, M Frolkis, S E Holt, C P Chiu, G B Morin, C B Harley, J W Shay, S Lichtsteiner, W E Wright. Science 1998
13

Rapid Loss of RNA Detection by In Situ Hybridization in Stored Tissue Blocks and Preservation by Cold Storage of Unstained Slides.
Javier A Baena-Del Valle, Qizhi Zheng, Jessica L Hicks, Helen Fedor, Bruce J Trock, Colm Morrissey, Eva Corey, Toby C Cornish, Karen S Sfanos, Angelo M De Marzo. Am J Clin Pathol 2017
24
13

The mutational landscape of lethal castration-resistant prostate cancer.
Catherine S Grasso, Yi-Mi Wu, Dan R Robinson, Xuhong Cao, Saravana M Dhanasekaran, Amjad P Khan, Michael J Quist, Xiaojun Jing, Robert J Lonigro, J Chad Brenner,[...]. Nature 2012
13

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.
Jack Cuzick, Gregory P Swanson, Gabrielle Fisher, Arthur R Brothman, Daniel M Berney, Julia E Reid, David Mesher, V O Speights, Elzbieta Stankiewicz, Christopher S Foster,[...]. Lancet Oncol 2011
438
13

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy.
Nicholas Erho, Anamaria Crisan, Ismael A Vergara, Anirban P Mitra, Mercedeh Ghadessi, Christine Buerki, Eric J Bergstralh, Thomas Kollmeyer, Stephanie Fink, Zaid Haddad,[...]. PLoS One 2013
352
13

Luminal cells are favored as the cell of origin for prostate cancer.
Zhu A Wang, Roxanne Toivanen, Sarah K Bergren, Pierre Chambon, Michael M Shen. Cell Rep 2014
74
13

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Scott A Tomlins, Daniel R Rhodes, Sven Perner, Saravana M Dhanasekaran, Rohit Mehra, Xiao-Wei Sun, Sooryanarayana Varambally, Xuhong Cao, Joelle Tchinda, Rainer Kuefer,[...]. Science 2005
13


BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Jake E Delmore, Ghayas C Issa, Madeleine E Lemieux, Peter B Rahl, Junwei Shi, Hannah M Jacobs, Efstathios Kastritis, Timothy Gilpatrick, Ronald M Paranal, Jun Qi,[...]. Cell 2011
13

Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
Michael C Haffner, Christopher Weier, Meng Meng Xu, Ajay Vaghasia, Bora Gürel, Berrak Gümüşkaya, David M Esopi, Helen Fedor, Hsueh-Li Tan, Ibrahim Kulac,[...]. J Pathol 2016
42
13

Integrative genomic profiling of human prostate cancer.
Barry S Taylor, Nikolaus Schultz, Haley Hieronymus, Anuradha Gopalan, Yonghong Xiao, Brett S Carver, Vivek K Arora, Poorvi Kaushik, Ethan Cerami, Boris Reva,[...]. Cancer Cell 2010
13

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
272
13

MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
Tsuyoshi Iwata, Denise Schultz, Jessica Hicks, Gretchen K Hubbard, Laura N Mutton, Tamara L Lotan, Carlise Bethel, Matthew T Lotz, Srinivasan Yegnasubramanian, William G Nelson,[...]. PLoS One 2010
91
13

Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer.
Antje Krohn, Fabian Freudenthaler, Silvia Harasimowicz, Martina Kluth, Sarah Fuchs, Lia Burkhardt, Phillip Stahl, Maria C Tsourlakis, Melanie Bauer, Pierre Tennstedt,[...]. Mod Pathol 2014
47
13

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
615
13

Clinical implications of PTEN loss in prostate cancer.
Tamara Jamaspishvili, David M Berman, Ashley E Ross, Howard I Scher, Angelo M De Marzo, Jeremy A Squire, Tamara L Lotan. Nat Rev Urol 2018
162
13

DKC1 overexpression associated with prostate cancer progression.
P Sieron, C Hader, J Hatina, R Engers, A Wlazlinski, M Müller, W A Schulz. Br J Cancer 2009
62
13


Dyskerin and TERC expression may condition survival in lung cancer patients.
Marianna Penzo, Vienna Ludovini, Davide Treré, Annamaria Siggillino, Jacopo Vannucci, Guido Bellezza, Lucio Crinò, Lorenzo Montanaro. Oncotarget 2015
16
18

Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities.
Levent Trabzonlu, Ibrahim Kulac, Qizhi Zheng, Jessica L Hicks, Michael C Haffner, William G Nelson, Karen S Sfanos, Onur Ertunc, Tamara L Lotan, Christopher M Heaphy,[...]. Cold Spring Harb Perspect Med 2019
8
37

The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer.
Heidrun Gevensleben, Dimo Dietrich, Carsten Golletz, Susanne Steiner, Maria Jung, Thore Thiesler, Michael Majores, Johannes Stein, Barbara Uhl, Stefan Müller,[...]. Clin Cancer Res 2016
93
13


Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
Cheryl M Koh, Ekta Khattar, Shi Chi Leow, Chia Yi Liu, Julius Muller, Wei Xia Ang, Yinghui Li, Guido Franzoso, Shang Li, Ernesto Guccione,[...]. J Clin Invest 2015
85
13

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
496
13

Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and Cancer.
Wanil Kim, Andrew T Ludlow, Jaewon Min, Jerome D Robin, Guido Stadler, Ilgen Mender, Tsung-Po Lai, Ning Zhang, Woodring E Wright, Jerry W Shay. PLoS Biol 2016
74
13

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.
A A Chiappori, T Kolevska, D R Spigel, S Hager, M Rarick, S Gadgeel, N Blais, J Von Pawel, L Hart, M Reck,[...]. Ann Oncol 2015
80
13

A highly selective telomerase inhibitor limiting human cancer cell proliferation.
K Damm, U Hemmann, P Garin-Chesa, N Hauel, I Kauffmann, H Priepke, C Niestroj, C Daiber, B Enenkel, B Guilliard,[...]. EMBO J 2001
305
13

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
203
13

Telomerase-independent regulation of ATR by human telomerase RNA.
Martijn Kedde, Carlos le Sage, Anja Duursma, Eitan Zlotorynski, Bart van Leeuwen, Wouter Nijkamp, Roderick Beijersbergen, Reuven Agami. J Biol Chem 2006
52
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.